IN VIVO’s Deals Of The Month: October 2015
IN VIVO’s editors pick October's top alliance, financing and M&A deals (free with registration).
You may also be interested in...
Endologix will acquire TriVascular Technologies in a $211 million deal expected to close in January. Company execs say they will now be better prepared to go up against larger players in the abdominal aortic aneurysm endovascular device space, offering the broadest set of AAA indications on the market.
In Vivo's editors pick January's most significant deals, including Roche's acquisition of Flatiron and Moderna's latest big private fundraising. (Free article.)
In Vivo's editors pick January's most significant deals, including an alliance of players new to health care and Celgene's big buys. (Free article.)